Testimonials

Background stories of how others approached and experienced their European Horizon funding trajectory.

Found 53 testimonials
Health University University College

SHIFT-HUB: uptake of Smart Health technologies & services, with Thomas More & Ugent as official partners

Source: HaDEA
Read at original location 
Civil Security Commune

ONELAB: City of Hasselt contribute to development of Rapid Response Mobile Labs

The City of Hasselt took part in the ONELAB project (2022–2025) as an end user. The project was funded under Horizon Europe (HORIZON-CL3-2021-DRS-01-05) and focused on developing modular Rapid Response Mobile Laboratories (RRML). These laboratories are designed for rapid deployment in a variety of settings to support disease monitoring.
Read more
Agro-Food, Environment Missions Research Centre

VLIZ: coordinator of INSPIRE - Innovative solutions for plastic free European rivers

Source: European Commission
Read at original location 
Climate, Energy, Mobility Large Company

DEME Group NV in Apollo: Ammonia as an alternative fuel to decarbonise shipping

Source: CINEA
Read at original location 
Climate, Energy, Mobility SME Research Centre

RSTER, BRING vzw & Flanders Make in Hypobatt: Hyper powered vessels battery charging systems

Source: CINEA
Read at original location 
Research Infrastructures

EHRI-IP - European Holocaust Research Infrastructure

The European Holocaust Research Infrastructure Implementation Phase (EHRI-IP) project was funded under Horizon Europe call topic HORIZON-INFRA-2023-DEV-01-02. The project duration was two years and came to an end in February 2026. The main objective of the EHRI-IP project was to undertake all necessary legal, financial and strategic work to have a permanent organisation or ERIC (European Research Infrastructure Consortium) fully operational by the end of the implementation phase. The project consortium consisted of 14 partners from 13 countries. Read more about the project and the contribution of Flemish partner Kazerne Dossin in this testimonial.
Read more
Climate, Energy, Mobility Research Centre

AENEAS – Innovative energy storage systems onboard vessels

Funded under Horizon Europe (HORIZON-CL5-2022-D5-01-02), running from 2023 to 2026, AENEAS advanced the development of innovative electric energy storage solutions tailored for waterborne transport. The project has also created tools & platforms to support the optimal integration of new energy storage systems into vessels, assess their impact on overall system efficiency, and quantify potential reductions in greenhouse gas emissions. The project consortium, led by Flanders Make, consists of 14 partners from 8 countries. Read more about the project in this testimonial.
Read more
Digital, Industry & Space University

KU Leuven in Bridges 5.0 - part of the data skills community

Source: HaDEA
Read at original location 
Research Infrastructures Agro-Food, Environment Research Centre

ANERIS - Next generation tools for sensing and monitoring marine-life

Funded under Horizon Europe (HORIZON-INFRA-2022-TECH-01) and running from 2023 to 2026, the ANERIS project aims to tackle the rapid loss of ocean biodiversity. The project’s main objective is to develop, test and implement the next generation of scientific instrumentation tools and methods for sensing and monitoring marine-life. Another key concept of the project is the introduction of the concept of Operational Marine Biology (OMB) as a biodiversity information system. The project consortium consists of 25 partners from 13 countries. Read more about the project and the contribution of Flemish partner VLIZ in this testimonial.
Read more
Culture and society Other

STUK Kunstencentrum in DanceMap: mapping Europe's hidden dance heritage

Source: European Commission
Read at original location 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of VLAIO
Logo of FWO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn